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I In nt tr ro od du uc ct ti io on n
Familial  adenomatous  polyposis  (FAP)  is
characterized by the development of hundreds to
thousands of adenomas throughout the entire colon
and rectum, which if not removed will almost certainly
result in the development of colorectal cancer [1].
Variance in disease expression has also been described
and is typified by fewer colonic and rectal adenomas
(usually fewer than 100), later age of onset and
a reduced likelihood of colorectal cancer development.
Variant  forms  of  FAP  are  known  as  attenuated
A Ab bs st tr ra ac ct t
Familial adenomatous polyposis (FAP) is characterized by the presence of hundreds to thousands of adenomas
that carpet the entire colon and rectum. Nonsense and frameshift mutations in the adenomatous polyposis coli
(APC) gene account for the majority of mutations identified to date and predispose primarily to the typical disease
phenotype. Some APC mutations are associated with a milder form of the disease known as attenuated FAP .
Virtually all mutations that have been described in the APC gene result in the formation of a premature stop
codon and very little is known about missense mutations apart from a common Ashkenazi Jewish mutation
(1307K) and a British E1317Q missense change. The incidence of missense mutations in the APC gene has
been underreported since the APC gene lends itself to analysis using an artificial transcription and translation
assay known as the Protein Truncation Test (PTT) or the In Vitro Synthetic Protein assay (IVSP). 
In this report we have used denaturing high performance liquid chromatography to analyse the entire coding
sequence of the APC gene to determine if a cohort of patients adhering to the diagnostic criteria of FAP to
assess the frequency of missense mutations in the APC gene. Altogether 112 patients were studied and 22
missense mutations were identified. From the total of 22 missense changes, 13 were silent changes and the
remaining 9 resulted in amino acid substitutions. One or more of these changes were identified multiple times
in 62.5% of the population under study. 
The results reveal that missense mutations in the APC gene appear not to radically alter protein function but
may be associated with more subtle processing of RNA transcripts which in turn could result in the expression
of differentially spliced forms of the APC gene which may interfere with the functional activity of the APC protein. H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2004; 2(2) 82
adenomatous polyposis (AAPC) or the flat adenoma
syndrome [2, 3]. The population incidence of FAP is
approximately  1:7000  according  to  the  Danish
Polyposis Registry and it affects both sexes equally. 
The  genetic  basis  of  FAP  was  first  localized  to
chromosome 5q in 1986 and the region localized to
5q21 in 1987 [4, 5]. In 1991 a gene for FAP was
identified and called the APC gene [6-9]. The APC gene
is composed of 15 exons, the first 14 being relatively
small whereas exon 15 is extremely large (6500 bp),
representing approximately 75% of the coding sequence. 
The APC protein is multifunctional and its primary
role appears to be linked to the breakdown of β-catenin
via the ubiquitin degradation pathway [10]. Several other
proteins not associated with that pathway have been
shown to bind to the APC protein suggesting a diversity
of function [11, 12]. The majority of mutations occur
within a section of the gene known as the mutation
cluster region bounded by codons 1286 and 1513 [13]. 
Since the APC consists of a large contiguous coding
sequence of DNA (exon 15) it lends itself to analysis
by the protein truncation test (PTT). The PTT is unique
in  that  it  is  an  assay,  which  specifically  detects
premature  termination  signals  using  an  artificial
transcription translation assay but is not capable of
identifying missense changes, which may have an affect
of protein function and consequently disease risk [14].
Most groups studying the APC gene tend to use the
PTT and have not necessarily submitted samples for
more intensive interrogation. Added to this there are
few reports detailing missense changes in the APC gene
except for two polymorphisms, I1307K and E1317Q,
both of which have been associated with an increased
risk of developing multiple adenomas and colorectal
cancer, for review see Fearnhead et al 2001 [15].
Additional missense changes have been reported in
one series of FAP patients that identified several different
polymorphisms, the majority of which were silent
changes [16]. Few other reports have been published
that describe missense changes in the APC gene [13,
17] and their relationship to disease expression. The
paucity of missense mutations identified in the APC
gene is in contrast to such changes identified in BRCA1,
BRCA2 and genes involved in DNA mismatch repair.
Several missense mutations identified in BRCA1, BRCA2
and the DNA mismatch repair genes are clearly
associated with disease risk as they unequivocally result
in a perturbation of protein function [18, 19]. In
contrast, all missense changes that have been identified
in the APC gene have not been categorically linked
with  a change  in  protein  function.  It  is  only  by
association  that  missense  changes  have  been
implicated in the risk of developing FAP [20]. 
In this report we have screened the entire coding
region of the APC gene by DHPLC analysis in a large
series of patients to determine the frequency of missense
changes in the APC gene and to assess their role in the
development of florid polyposis. From a series of 112
patients a total of 22 different missense changes were
identified of which 13 were silent polymorphisms and
9 resulted in an amino acid change. 
M Ma at te er ri ia al ls s   a an nd d   m me et th ho od ds s
P Pa at ti ie en nt ts s
A group of 112 unrelated patients of British and
European descent fulfilling the diagnostic criteria for
FAP were included in the study for mutations in the APC
gene. Probands were identified at family cancer clinics
that cover the entire state of New South Wales, including
the Australian Capitol Territory. All probands gave
informed consent for genetic testing. In addition to the
FAP patients used for this study a series of unidentifiable
control samples of DNA taken from a population at
random were also included in the analysis. Of the 112
patients, 12 presented with colonic and extra-colonic
disease, 4 were described as having attenuated disease
and there were 14 patients who did not have a family
history of disease but did present with florid polyposis.
The remaining 82 patients only presented with colonic
polyposis  but  did  have  strong  family  histories  of
colorectal  cancer  consistent  with  an  autosomal
dominant inheritance pattern. For statistical purposes
patients were classified into three categories: mild,
moderate and severe disease. Mild disease represented
patients over the age of 60 with multiple polyps (over
20),  moderate  disease  represented  patients  with
polyposis (over 100) and cancer over the age of 60
and severe disease was considered to cover typical
symptoms of polyposis (100s to 1000s of adenomas)
under the age of 50 with or without cancer. 
D DN NA A  i is so ol la at ti io on n
Genomic DNA was isolated from Na2EDTA blood
according to the method described by Miller et al 1988
[21]. 
D D- -H HP PL LC C  a an na al ly ys si is s
PCR  amplification  for  DHPLC  analysis  was
performed using primers that were identical to those
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described for DGGE (except that the GC-clamp was
not included) analysis of exons 1 – 14 of the APC gene
[22] and primers designed specifically for exon 15 (see
Table 1). The reaction consisted of 1.0 µM each
primer, 1U Platinum Taq (Gibco-BRL), 2 – 5 mM
MgCl2 and 200 µM each dNTP . PCR amplification was
achieved by an initial denaturation at 94°C for 5 min
followed  by  14  cycles  of  94°C  for  1 min,  7°C
touchdown range for 1.5 min and 72°C for 2 min,
then 20 cycles using an annealing temperature 0.5°C
lower than the bottom of the touchdown range. The
initial annealing step was performed as a touchdown
protocol with a 7°C range, decreasing 0.5°C/cycle
over 14 cycles. This was followed by a final extension
step at 72°C for 10 min, a final denaturation step at
95°C for 5 min and a slow annealing step from 95°C
to  65°C  over  30  min  to  promote  heteroduplex
formation. The PCR was performed on a PCR express
(Hybaid) instrument equipped with a heated lid to avoid
the use of mineral oil. 
DHPLC analysis was performed using a Varian Helix
system (Varian, Inc., Walnut Creek, CA). PCR products 
(2-5 µl) were injected directly into a DNA Eclipse
(Hewlett Packard) or Helix (Varian) column and
eluted  from  the  column  using  an  increasing
acetonitrile gradient and a column oven temperature
suitable for each exon and fragment of the APC gene
(see Table 1). Heteroduplexes formed during PCR of
a heterozygote sample were detected as an additional
peak  eluting  before  the  homoduplex  peak.  The
detection of heteroduplexes was made simpler with the
use of DHPLC review software supplied as a prototype
from Varian. The predicted melting temperatures of
the double stranded DNA products were obtained by
using  the  DHPLC-MELT  program  available  from
http://www.insertion.stanford.edu/melt.ht. 
D DN NA A  s se eq qu ue en nc ci in ng g
All polymorphisms were subject to DNA sequencing
to determine the precise genetic change on a semi-
automated sequencing unit (model 310, Perkin-Elmer
Applied Biosystems Division, Foster City, CA). 
S St ta at ti is st ti ic cs s
Linkage disequilibrium was assessed by estimating
a correlation coefficient (program kindly provided by
D.  Clayton,  personal  communication)  and  using
a likelihood ratio test. Haplotype frequency was inferred
using the E-M algorithm [23]. All statistics were
performed using STATA version 8.0 software [24]. 
T Ta ab bl le e   1 1. .   P Pr ri im me er rs s   u us se ed d   f fo or r   t th he e   a an na al ly ys si is s   o of f   e ex xo on n   1 15 5   o of f   t th he e   A AP PC C   g ge en ne e
S Se eg gm me en nt t S Se eq qu ue en nc ce e O Ov ve en n   
T Te em mp pe er ra at tu ur re e   ( (
o oC C) )
FAPex15.1For gttactgcatacacattgtgac 50,59
FAPex15.1Rev gctttttgtttcctaacatgaag
FAPex15.2For agtacaaggatgccaatattatg 50,59
FAPex15.2Rev acttctatctttttcagaacgag
FAPex15.3For atttgaatactacagtgttaccc 50,54,60
FAPex15.3Rev cttgtattctaatttggcataagg
FAPex15.4For ctgcccatacacattcaaacac 50,55,57
FAPex15.4Rev tgtttgggtcttgcccatctt
FAPex15.5For agtcttaaatattcagatgagcag 50,52
FAPex15.5Rev gtttctcttcattatattttatgcta
FAPex15.6For aagcctaccaattatagtgaacg 50,59
FAPex15.6Rev agctgatgacaaagatgataatg
FAPex15.7For aagaaacaatacagacttattgtg 50,54,59
FAPex15.7Rev atgagtggggtctcctgaac
FAPex15.8For atctccctccaaaagtggtgc 50,60
FAPex15.8Rev tccatctggagtactttccgtg
FAPex15.9aFor agtaaatgctgcagttcagagg 50,58
FAPex15.9aRev catcatcatctgaatcatcta
FAPex15.9bFor accaagagaaagaggcag 50,54,59
FAPex15.9bRev ccgtggcatatcatccccc
FAPex15.10For gcccagactgcttcaaaattacc 50, 61
FAPex15.10Rev gagcctcatctgtacttctgc
FAPex15.11For ccctccaaatgagttagctgc 50,54,60
FAPex15.11Rev ttgtggtataggttttactggtg
FAPex15.12For acccaacaaaaatcagttagatg 50,57
FAPex15.12Rev gtggctggtaactttagcctc
FAPex15.13For atgatgttgacctttccaggg 50,58
FAPex15.13Rev gctcagtctctttgataggttc
FAPex15.14For ctgagttctctcagtgacattgac 50,58
FAPex15.14Rev gttctgaatctggtctctg
FAPex15.15For tatgggtggcatattaggtg 50,59
FAPex15.15Rev cctttactttcagattctatc
FAPex15.16For aggcccacgaattctaaaacc 50,54,58
FAPex15.16Rev cctggcaacagggcttaattc
FAPex15.17For gaaggtcaaacagccacc 50,59
FAPex15.17Rev ggcattcttggataaacctg
FAPex15.18For catctccaggtagacagatgag 50,59
FAPex15.18Rev cttaaaactggagtttgtgcctg
FAPex15.19For ctccatcatctagaccagc 50,61
FAPex15.19Rev cactggattctgatgaagc
FAPex15.20For tggagaagaactggaagttc 50,58
FAPex15.20Rev gggagatcttccagatctagg
FAPex15.21For acagaggatgtttgggtgag 50,60
FAPex15.21Rev gcttgagctgctagaactg
FAPex15.22For cctgtatcagagactaatg 50,55,60
FAPex15.22Rev caaaatgtctatatagcagttgH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2004; 2(2) 84
R Re es su ul lt ts s
In total, 70 patients out of the 112 harboured
missense changes in the APC gene and out of these
a significant proportion harboured multiple changes.
There were 13 silent polymorphisms (mutations that do
not change an amino acid or elicit aberrant splicing)
identified throughout the APC gene. The majority of these
were located in exon 15 of the APC gene and are listed
in Table 2. A total of eight new silent polymorphisms were
identified, one in exon 12 and seven in exon 15 (see Fig.
1 for their relative position in the APC gene). In exon 15
a total of 6 silent polymorphisms were identified and
5 normal variants (occurring more than twice in the
population under study) none of which appeared to be
associated with disease. A summary of the frequency of
the silent changes is shown in Table 3, indicating their
frequency and combination. Two of the normal variants
(positions 5034 and 5880) were for the majority of
patients in linkage disequilibrium with one another. A third
Rodney J. Scott et al
T Ta ab bl le e   2 2. .   S Si il le en nt t   p po ol ly ym mo or rp ph hi is sm ms s   i in n   t th he e   A AP PC C   g ge en ne e
E Ex xo on n N Nu uc cl le eo ot ti id de e   c ch ha an ng ge e C Co od do on n N Nu um mb be er r   o of f   t ti im me es s   o ob bs se er rv ve ed d N Ne ew w
12 1554 G>A* 518 1 Yes
13 1635 A>G* 545 13 No
15 3471 G>A 1157 1 Yes
5 3499 G>A 1167 1 Yes
15 3606 T>C 1202 1 Yes
15 4326 T>A* 1442 1 Yes
15 4479 G>A* 1493 9 No
15 4497 G>A 1499 2 Yes
15 5034 A>G* 1678 40 No
15 5268 G>T* 1756 21 No
15 5880 A>G* 1960 45 No
15 6948 A>G 2316 1 Yes
15 6921 G>A 2307 1 Yes
*Causative mutation identified in patients with this variant
T Ta ab bl le e   3 3. .   F Fr re eq qu ue en nc cy y   o of f   m mi is ss se en ns se e   c ch ha an ng ge es s   i id de en nt ti if fi ie ed d   a an nd d   t th he ei ir r   a as ss so oc ci ia at ti io on n   w wi it th h   o on ne e   a an no ot th he er r   i in n   t th he e   A AP PC C   g ge en ne e
N Nu um mb be er r   o of f   t ti im me es s   i id de en nt ti if fi ie ed d
Codon/Codon 545 1493 1499 1678 1756 1822 1960
545 1 13 3* * 3 1 12 11 3 12
1493 9 9 05 54 7
1499 2 2 21 12
1678 4 40 0 17 18 35
1756 2 21 1 61 7
1822 2 23 3 20
1960  4 48 8
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F Fi ig g. .   1 1. .   S Sc ch he em ma at ti ic c   d di ia ag gr ra am m   o of f   t th he e   A AP PC C   g ge en ne e   i in nd di ic ca at ti in ng g   t th he e   l lo oc ca at ti io on n   o of f   t th he e   m mi is ss se en ns se e   c ch ha an ng ge es s   i id de en nt ti if fi ie ed d   i in n   t th he e   A AP PC C   g ge en ne e. .   M Mi is ss se en ns se e   m mu ut ta at ti io on ns s
a ar re e   i in nd di ic ca at te ed d   a ab bo ov ve e   t th he e   g ge en ne e   a an nd d   s si il le en nt t   p po ol ly ym mo or rp ph hi is sm ms s   a ar re e   b be el lo ow w   t th he e   g ge en ne e
O Ol li ig go om me er ri is sa at ti io on n A Ar rm ma ad di il ll lo o 1 15 5   a am mi in no o   a ac ci id d                        2 20 0   a am mi in no o   a ac ci id d B Ba as si ic c E EB B1 1   b bi in nd di in ng g H Hu um ma an n   d di is sc cs s
d do om ma ai in n r re eg gi io on n r re ep pe ea at ts s r re ep pe ea at ts s d do om ma ai in n s si it te e l la ar rg ge e   b bi in nd di in ng g   s si it te e
* Missense changes
# Silent polymorphisms
# ## # # ## #
* * * * * * * * * * * *      * *      * *            * *
# ## ## # # ## ## #
0 0 3 35 50 0 7 70 00 0 1 10 05 50 0 1 14 40 00 0
C Co od do on ns s
1 17 75 50 0 2 21 10 00 0 2 24 45 50 0 2 28 80 00 0
# #               # #                        # #
common variant (position 1635) appeared to be in
almost  complete  linkage  disequilibrium  with  both
changes. The fourth common variant at position 4479
was only rarely observed segregating with more than one
other common variant. The common variant at position
5034 was observed 4 separate times in isolation in
4 unrelated patients. Ten patients were shown to harbour
the 5880 common variant that was not in linkage
disequilibrium with any other change. The correlation
coefficients capturing the level of linkage disequilibrium
between these polymorphisms are shown in Table 4. As
can be seen, the polymorphisms at positions 5034, 5465
and 5880 are in strong linkage disequilibrium with each
other and in turn with 4479 (p<0.001). This degree of
linkage disequilibrium leads to 1 common haplotype and
a series of much rarer haplotypes, listed in Table 5.
Almost 75% of all chromosomes have the wild type allele
at all 4 positions (5034, 5465, 5880 and 4479). 
From the 112 index cases studied a total of 42 patients
harboured 9 missense changes dispersed across the
coding region of the APC gene (see Fig. 1 and Table 6).
Examination  of  the  clinical  features  of  families
harbouring missense mutations in the APC gene did
not reveal any specific characteristic that could be used
for potential selection purposes (see Table 7 for details).
One  missense  variation  was  considered  to  be
a common variant and there were five missense
T Ta ab bl le e   4 4. .   A Al ll le el li ic c   c co or rr re el la at ti io on n   c co oe ef ff fi ic ci ie en nt ts s   ( (r r) )   b be et tw we ee en n   t tw wo o   p po ol ly ym mo or rp ph hi is sm ms s
P Po ol ly ym mo or rp ph hi is sm ms s 4 44 47 79 9 4 44 49 97 7 5 50 03 34 4 5 58 88 80 0 5 54 46 65 5
4479 1
4497 -0.04 1
(p=0.702) 
5034 0.13 0.16 1
(p=0.106)  (p=0.040)
5880 0.21 0.13 0.51 1
(p=0.006)  (p=0.063)  (p=<0.001)
5465 0.16 0.08 0.35 0.30 1
(p=0.083)  (p=0.405) (p=<0.001) (p=<0.001)
P – value of likelihood ratio testH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2004; 2(2) 86
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mutations that have not previously been described.
From the 42 patients, 4 were found to harbour two
missense  changes  of  which  two  patients  were
homozygotes for one common variant (D1822V), one
had two mutations (R1640W and A2696T) and one
had 2 common variants (D1822V and S2621C). For
a complete list of missense changes see Table 6 (for
details of the site and affect of the changes). A total of
28 patients were found to be harbouring a common
variant (D1822V), which was deemed not to be
associated with any increased risk of colorectal cancer.
This was further verified in a series of 67 unaffected
healthy control subjects and found to be present at
a frequency of 40%, which was not statistically different
from the group of FAP patients. Within this group, the
same  frequency  of  homozygote  individuals  was
observed as found in the patient population. 
Two of the patients were found to harbour a previously
reported causative missense change (S2621C), which
results in a change from a serine to a cysteine. This
change could not be shown to exclusively segregate with
disease status. 
Of the remaining missense mutations, 5 were
identified in more than one unrelated patient and four
appeared to be unique. Two mutations were identified
in the mutation cluster region (E1317Q and M1413V)
and the remaining two were located towards the
extreme  3’  end  of  the  APC  gene  (G2502S  and
A2696T).  One  missense  mutation  (L1129S)  was
identified immediately upstream of the β-catenin binding
region of the APC gene in two unrelated patients. 
Only  three  changes  were  identified  within  the 
β-catenin down regulatory region of the APC gene. One
of the changes (M1413V) found in the β-catenin down
regulatory region was homozygous in one patient who
also harboured the common D1822V polymorphism.
In  further  testing  of  other  family  members  this
combination was also identified in unaffected relatives.
The second patient found to have the M1413V change
was subsequently shown to harbour a mutation, which
resulted in a premature termination codon. 
Segregation analysis of the D1822V and the S2621C
changes in one family revealed no apparent association
with disease when both alleles were inherited together.
One individual was heterozygote for D1822V and
S2621C and affected with disease; three healthy siblings
were homozygote for the D1822V change, of which two
also were heterozygote for the S2621C mutation. 
There were a series of patients from this study group
that harboured more than one silent and/or missense
change. There were 13 patients who harboured 4 or
more polymorphisms, from which 2 unrelated patients
were shown to harbour seven common alterations in the
APC gene (see Table 3 for summary). 11 (9.8%) of the
patients included in this study were subsequently shown
to harbour germline causative changes in the APC gene
that resulted in either premature termination codons
(10/11) or a complete gene deletion (1/11). All of these
patients harboured one or more missense mutations. 
Examination  of  the  clinical  features  of  families
harbouring missense mutations in the APC gene indicated
some suggestive associations, although none reached
statistical significance (see Tables 7 and 8 for details). As
mentioned previously, the most common polymorphisms,
at positions 5034, 5880 and 5465, were in reasonably
high linkage disequilibrium and so these were considered
as a group. Having a polymorphic allele at one or more
of  these  3 sites  increased  the  risk  of  having
moderate/severe disease by 1.6 fold (95% CI 0.7-3.6),
as shown in Table 8a. Furthermore, the polymorphism at
position 4479 appeared to have a protective effect,
T Ta ab bl le e   5 5. .   H Ha ap pl lo ot ty yp pe e   f fr re eq qu ue en nc ci ie es s   
L Lo oc cu us s N Nu um mb be er r P Pe er rc ce en nt ta ag ge e
1.1.1.1 164 73.21*
1.1.1.2 1 0.45
1.1.2.1 5 2.23
1.1.2.2 0 0
1.2.1.1 9 4.02
1.2.1.2 1 0.45
1.2.2.1 3 1.34
1.2.2.2 1 0.45
2.1.1.1 3 1.34
2.1.1.2 0 0
2.1.2.1 2 0.89
2.1.2.2 0 0
2.2.1.1 18 8.04*
2.2.1.2 2 0.89
2.2.2.1 12 5.36*
2.2.2.2 3 1.34
Total 224 100.00
Locus position 1, 2, 3, 4 correspond to 5034, 5880, 5465, and 4479 
respectively. Each locus has two alleles: 1 = wild type and 2 = mutant type H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2004; 2(2) 87
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T Ta ab bl le e   6 6. .   M Mi is ss se en ns se e   c ch ha an ng ge es s   i id de en nt ti if fi ie ed d   i in n   e ex xo on n   1 15 5   o of f   t th he e   A AP PC C   g ge en ne e
E Ex xo on n N Nu uc cl le eo ot ti id de e    C Co od do on n    R Re ep po or rt te ed d   i in n N Nu um mb be er r   o of f N Ne ew w   
H Hu um ma an n   G Ge en no om me e   D Da at ta ab ba as se e o ob bs se er rv va at ti io on ns s
15.5 3386 T>C L1129S No 2 Yes
15.7 3949 G>C E1317Q Yes 2 No
15.8 4237 A>G* M1413V No 1 Yes
15.10 4918 C>T R1640W Yes 1 No
15.12 5465 A>T* D1822V Yes 23 No
15.19 7406 C>T* S2469F No 2 Yes
15.19 7504 G>A* G2502S No 3 Yes
15.20 7862 C>G S2621C Yes 2 No
15.21 8068 G>A A2696T No 1 Yes
*Causative mutation identified in patients harbouring these missense changes
decreasing the risk of moderate/severe disease to 0.4
(95% CI 0.1-2.8) as shown in Table 8b. 
All the missense changes were studied using an
algorithm that identifies the presence of exon splice
enhancer (ESE) regions within the coding sequence
genes (http://genes.mit.edu/cgi-bin/rescue-ese/). The
results of this investigation revealed that the majority
of changes did not result in any putative ESE binding
site changes. There were, however, nine polymorphisms
(both silent changes and missense mutations) that the
prediction algorithm identified as having an effect (see
Table 9). Of the nine changes 6 were predicted to result
in the addition of one or more ESE binding motifs and
2 – the loss of one or more motifs. 
D Di is sc cu us ss si io on n
There has been a paucity in reporting missense
changes in the APC gene by virtue of the fact that the
majority of investigators use the PTT to screen for
mutations in the APC gene. The PTT is an excellent screen
for mutations that either result in immediate termination
codons  or  for  insertion  or  deletion  mutations  that
eventuate in frameshifts culminating in downstream stop
codons but it cannot identify amino acid substitutions.
Little information is available in the published literature
about missense changes, silent or not, that have the
capacity to affect the functioning of the expressed protein.
In this report we have specifically targeted the identification
of missense changes in the APC gene to determine if any
of them could be unequivocally associated with an
increased risk of colorectal cancer. 
Detailed examination of exon 15 of the APC gene
revealed in the study population 6 silent polymorphisms
that occurred with a frequency varying from 1.8% to
42%. Some of the polymorphisms were in linkage
disequilibrium with one another, and these have
previously been reported [25]. One haplotype accounts
for almost 75% of all chromosomes; however, linkage
disequilibrium is not complete and is suggestive of
recombination between these polymorphisms. 
Irrespective  of  linkage  disequilibrium  being
incomplete it was sufficient to allow for an analysis of
the contribution one or more missense changes can
have to disease. In the results presented herein we were
able to identify an association (although not statistically
significant in this small sample population) between
three missense changes (at positions 5034, 5465
and/or 5880), which increases the risk of developing
moderate to severe disease and an apparent protective
affect of missense change at position 4479. 
These results present a challenge to our concept of
disease risk as they cannot be readily explained by
examining the functional affects on the APC protein.
Recently, a new notion has been put forward to explain
the paucity of causative missense mutations in the APC
gene, known as the ”Just-Right” signalling hypothesis.
This theory suggests that APC driven tumourigenesis is
related to the amount of residual β-catenin down
regulatory activity centred around the 7 β-catenin binding
and down regulatory regions in the APC protein. The loss
of these sites appears to be related to disease phenotype,
since if all are lost there is too much accumulation of 
β-catenin, which at a cellular level is fatal as it triggersH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2004; 2(2) 88
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codon 1822 26 – Male Yes Polyposis No
(hom) 48 48 Male Polyposis No
codon 1822 36 – Female Yes Polyposis No
43 – Male Bowel Cancer No
40 – Male Polyposis No
43 46 Male Bowel No
codon 2502* 39 53 Female Yes Polyposis Leiomyoma
49 – Male Polyposis Upper GI Polyposis
codon 1317 48 – Male Yes Polyposis No
35 – Male Polyposis No
codon 2502 45 – Male Yes Polyposis No
– 77 Male – Renal Cancer
– 60 Female – Multiple Myeloma
– 66 Female – Breast Cancer
codon 1129 12 29 Male No Polyposis  No
codon 1640 38 47 Male Yes Polyposis  CHRPE
and 2696 – 42 Male – Melanoma
– 57 Male Polyposis
– – Male Unknown Unknown
codon 1822 31 – Female Yes Polyposis No
(hom) 42 – Male Polyposis No
26 27 Male Bowel Cancer No
codon 2502 38 – Female Rectal Cancer No
Multiple adenomas
44 – Male Bowel Cancer
Multiple adenomas
– 80s Male Bowel Cancer No
28 – Female Multiple adenomas  No
34 – Male Multiple adenomas
codon 1129 62 – Male No Polyposis Bowel 
Cancer
Upper GI 
Polyposis
codon 1413* 35 – Female No Bowel Cancer No
*both these patients harboured premature termination codons in the APC gene (one in exon 4 and the other in exon 15, respectively), hom = homozygoteH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2004; 2(2) 89
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programmed cell death [26]. Partial retention of one or
more of the binding sites is likely to result in a severe
disease phenotype and promote the development of
colorectal cancer since there is sufficient control over 
β-catenin [27]. Since there are 7 β-catenin binding and
down regulatory regions in the APC gene the affect of
one or two missense changes in the APC gene would not
be sufficient to radically alter this important role of the
APC  protein.  Indeed,  we  were  able  to  perform
segregation analysis on one large family that harboured
three separate missense mutations, which showed that
the missense changes clearly did not segregate with
disease. This coupled with the notion that missense
changes will not be sufficient to alter the primary function
of the APC protein offers an explanation as to why
missense mutations occur so frequently in the APC gene
and second, why they do not result in disease. 
An alternative notion should also be considered
since it offers a novel and plausible explanation as to
why some missense changes have been described as
pathogenic. Most of the missense changes described
herein conform to the notion that missense changes
do not alter the function of the APC protein. There has
been little focus on the role of missense changes and
how they may relate to mRNA processing. Mutations
occurring at canonical splice sites are known to result
in splicing changes that can be pathogenic but more
recent evidence is beginning to shed light on the role
of exon splice enhancer and exon splice suppressor
motifs and their role in gene expression. 
Any alteration in the control of exon splicing could
potentially result in a RNA species that either contains more
or less genetic information. Importantly, if the change
results in a differentially spliced mRNA species, the resultant
splice variant will not necessarily be recognised as an error
and therefore not be removed by the process of nonsense
mediated mRNA decay since there will be no premature
stop codon to initiate this process. 
Examination of the changes elicited at the genetic
level suggest an alternative hypothesis explaining why
some missense changes are pathogenic and others are
not. For example, there have been extensive studies
examining the pathogenicity of the Ashkenazi I1307K
change, which has been implicated in disease risk. The
current explanation focuses on the position of this
missense  mutation  and  its  proximity  to  the  most
frequently described mutation at codon 1309, which
is associated with a severe disease phenotype [20].
Codon 1309 is located within the β-catenin binding
domain of APC (see Fig. 1). The I1307K change occurs
within the β-catenin binding domain and is believed
to disrupt the kinetics of β-catenin binding to APC. If
the ”Just-Right” signalling hypothesis is correct then it
is difficult to reconcile this conundrum. Similarly,
a second missense variant that has been associated
with  FAP ,  the  E1317Q  change,  is  even  more
problematic and the only suggestion to date has been
the creation of a hypermutable site [20, 28]. If the
genetic changes are assessed for their effect on the
presence of ESE motifs the results suggest that these
are especially important. Both of these changes result
in a change in ESE motif structure and are likely to have
more influence on differential mRNA splicing, which is
could result in the creation of mRNA species that would
result in proteins incapable of being fully functionally
active. The expected result of these changes would be
a mild phenotype consistent with the notion that
haploinsufficiency  is  sufficient  to  initiate  disease
development. The remaining question which has not
been addressed here would be: what reduction in full
length APC mRNA is required to change the likelihood
of disease development? 
In relation to the observed association between the
three missense changes (at codons 1678, 1960 and
D1822V) and disease severity this model does offer an
explanation as to the apparent pathogenicity of these
changes  and  the  ”Just-Right”  signalling  model.
Furthermore, the protective effect of the codon 1493
change can also be accommodated by this notion. 
In summary, none of the 13 polymorphisms or
9 missense changes could be unequivocally associated
with changing the functional role of the APC protein
and thereby the risk of developing polyposis. From the
22 changes identified 9 of them were associated with
a change in exon splice enhancer motifs that are more
likely to change disease risk via the production of
differential forms of the APC gene that could be
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p po ol ly ym mo or rp ph hi ic c   a al ll le el le es s   i id de en nt ti if fi ie ed d   a as s   b be ei in ng g   i in n   l li in nk ka ag ge e   d di is se eq qu ui il li ib br ri iu um m
a a. .   A As ss so oc ci ia at ti io on n   b be et tw we ee en n   p po ol ly ym mo or rp ph hi is sm ms s   a at t   5 50 03 34 4, ,   5 54 46 65 5, ,   5 58 88 80 0   
a an nd d   d di is se ea as se e   s se ev ve er ri it ty y
M Mo od de er ra at te e/ /s se ev ve er re e M Mi il ld d
At least 1 polymorphic allele 41 20
Wild type at all 3 sites 33 26
OR=1.62 (0.70-3.63) 
b b. .   A As ss so oc ci ia at ti io on n   b be et tw we ee en n   p po ol ly ym mo or rp ph hi is sm m   4 44 47 79 9   a an nd d   d di is se ea as se e   s se ev ve er ri it ty y
M Mo od de er ra at te e/ /s se ev ve er re e M Mi il ld d
Polymorphic allele 3 4
Wild type 71 42
OR=0.44 (95% CI 0.06-2.78) H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2004; 2(2) 90
capable of reducing the affective levels of APC protein
and thereby change disease risk. 
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